Me NaPhos MB Hyo 1
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Me NaPhos MB Hyo 1
- Generic name
- URINARY ANTISEPTIC ANTISPASMODIC
- Manufacturer
- Method Pharmaceuticals
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 2ae628e7-3b33-6a9a-e054-00144ff8d46c
- SPL ID
- 41b576a1-2a59-9f3c-e063-6394a90aec7d
- Version
- 8
- Effective date
- 2025-10-21
- Source export date
- 2026-09-28
- Source partition
- 12
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:28:06
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Me NaPhos MB Hyo 1 | openfda.brand_name | |
| generic name | URINARY ANTISEPTIC ANTISPASMODIC | openfda.generic_name | |
| manufacturer name | Method Pharmaceuticals | openfda.manufacturer_name | |
| ndc | package | 58657-454-01 | openfda.package_ndc |
| ndc | product | 58657-454 | openfda.product_ndc |
| ndc11 | package | 58657045401 | derived:openfda.package_ndc |
| rxcui | 1050325 | openfda.rxcui | |
| spl id | 41b576a1-2a59-9f3c-e063-6394a90aec7d | id | |
| spl set id | 2ae628e7-3b33-6a9a-e054-00144ff8d46c | set_id | |
| unii | OB570Z127K | openfda.unii | |
| unii | J50OIX95QV | openfda.unii | |
| unii | 8NAP7826UB | openfda.unii | |
| unii | 593YOG76RN | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS Do not exceed recommended dosage. If rapid pulse, dizziness, or blurring of vision occurs discontinue use immediately.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS Cardiovascula r – rapid pulse, flushing Central Nervous System – blurred vision, dizziness Respiratory – shortness of breath or troubled breathing Genitourinary – difficulty micturition, acute urinary retention Gastrointestinal – dry mouth, nausea/vomiting
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.